Umbilical cord Mesenchymal stem cell therapy (Institute Of Liver And Biliary Sciences)

N/A

Report date: 2025/07/22 20:00:10

Base Information

Drug NameUmbilical cord Mesenchymal stem cell therapy (Institute Of Liver And Biliary Sciences)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsAcute-On-Chronic Liver Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndia

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesInstitute Of Liver And Biliary Sciences, India

China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Liver And Biliary Sciences, India

Inactive CompaniesN/A

Active IndicationsAcute-On-Chronic Liver Failure

Inactive IndicationsN/A

Other Information

ATC CodeN/A